The albumin–bilirubin (ALBI) grade, a validated prognostic tool in cancers such as hepatocellular carcinoma, has not been evaluated in acute respiratory distress syndrome (ARDS). The gene discussed is ALB; the disease is hepatocellular carcinoma.